Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crystallized Phenol for Pilonidal Sinus Disease
NCT04681443Phase 4Completed
- Sponsor
- Gulhane Training and Research Hospital
- Start
- Jan 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of phenol in pilonidal sinus disease (2 arms), sponsored by Gulhane Training and Research Hospital. Primary endpoints: Short-term recurrence rate at 30 days and Healing time at 1 year. Started Jan 2018; status: completed.
02
Drugs
phenol
03
Conditions
pilonidal sinus disease
Beyond the preview
Go deeper on NCT04681443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04681443.